Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2
Introduction 8
2.1 What Is This Report About? 8
3 Definitions of
Markets Covered in the Report 9
3.1 lrug delivery devices 9
3.2
Inhalation Systems 9
3.2.1 Metered Dose Inhaler 9
3.2.2 Dry powder
inhaler 9
3.3 Infusion Systems 9
3.3.1 Infusion pumps 9
3.3.2
Syringe pumps 9
3.3.3 Disposable Infusion sets 10
4 Healthcare Sector
Review 11
5 Regulation System 12
5.1 Device Classification 12
5.2
Registration Process 12
5.3 Labeling Requirements 14
5.4 Import
Documentation 15
6 Pricing and Reimbursement 16
7 Distribution
Structure 17
8 Drug Delivery Devices In Mexico 18
8.1 Drug Delivery
Devices Cross Country Comparison (2000-2012) 18
8.2 Drug Delivery Devices,
Mexico, Overall Revenues ($ mn), 2000-2012 19
8.3 Drug Delivery Devices,
Mexico, Category Volume (Units), 2000-2012 23
8.4 Drug Delivery Devices,
Mexico Company share (2006-2007) 26
9 Infusion Systems In Mexico 27
9.1 Infusion Systems Overall Revenue (2000-2012) 27
9.2 Infusion Systems
Overall Volume (2000-2012) 29
9.3 Infusion Systems Average Price
(2000-2012) 30
9.4 Infusion Systems Distribution Share (2006-2007) 30
9.5 Infusion Systems, Mexico, Company Share (2006-2007) 31
10 Inhalation
Systems In Mexico 32
10.1 Inhalation Systems Overall Revenue (2000-2012)
32
10.2 Inhalation Systems Overall Volume (2000-2012) 34
10.3
Inhalation Systems Average Price (2000-2012) 36
10.4 Inhalation Systems
Distribution Share (2006-2007) 36
10.5 Inhalation Systems, Mexico, Company
Share (2006-2007) 37
11 3M Company Company Profile 38
11.1 Company
Overview 38
11.2 Value Chain Analysis 39
11.2.1 Manufacturing 39
11.2.2 Product Development 39
11.2.3 Sales and Marketing 40
12
AstraZeneca PLC Company Profile 41
12.1 Company Overview 41
13 Baxter
International Inc. Company Profile 42
13.1 Company Overview 42
13.2
Value Chain Analysis 43
13.2.1 Manufacturing 43
13.2.2 Product
Development 43
13.2.3 Sales and Marketing 44
14 Boehringer Ingelheim
GmbH Company Profile 45
14.1 Company Overview 45
14.2 Value Chain
Analysis 46
14.2.1 Manufacturing 46
14.2.2 Product Development 47
14.2.3 Sales and Marketing 47
15 GlaxoSmithKline plc Company Profile
48
15.1 Company Overview 48
16 Novartis Medical Nutrition Company
Profile 49
16.1 Company Overview 49
17 Appendix 50
17.1 Global
Markets Direct Research Methodology 50
17.2 Coverage 51
17.3 Secondary
Research 51
17.4 Primary Research 52
17.5 Models 52
17.6 Forecasts
53
17.7 Expert Panels 53
17.8 Currency Conversion 54
17.9 Contact
Us 55
17.10 Disclaimer 55
1.1 List of Tables
Table 1:
Drug Delivery Devices Cross Country Comparison (2000-2012) 18
Table 2:
Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 2000-2012 19
Table 3: Drug Delivery Devices, Mexico, Portfolio Analysis, 2000-2012
20
Table 4: Drug Delivery Devices, Mexico, Overall Revenues ($ mn),
Historic, 2000-2007 21
Table 5: Drug Delivery Devices, Mexico,
Overall Revenues ($ mn), Forecast, 2007-2012 22
Table 6: Drug
Delivery Devices, Mexico, Category Volume (Units), 2000-2012 23
Table 7:
Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2007
24
Table 8: Drug Delivery Devices, Mexico, Category Volume (Units),
Forecast, 2007-2012 25
Table 9: Drug Delivery Devices, Mexico Company
share by Revenue ($ mn), 2006-2007 26
Table 10: Infusion Systems,
Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 27
Table 11:
Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012
28
Table 12: Infusion Systems, Mexico, Overall Volume (Units),
Historic, 2000-2007 29
Table 13: Infusion Systems, Mexico, Overall
Volume (Units), Forecast, 2007-2012 29
Table 14: Infusion Systems,
Mexico, Average Price ($), Historic, 2000-2007 30
Table 15: Infusion
Systems, Mexico, Average Price ($), Forecast, 2007-2012 30
Table 16:
Infusion Systems, Mexico, Distribution Share by Revenue ($mn), 2006-2007
30
Table 17: Infusion Systems, Mexico, Company Share by Revenue ($
mn), 2006-2007 31
Table 18: Inhalation Systems, Mexico, Revenue ($
mn) by Segment, Historic, 2000-2007 32
Table 19: Inhalation Systems,
Mexico, Revenue ($ mn) by Segment, Forecast, 2007-2012 33
Table 20:
Inhalation Systems, Mexico, Overall Volume (Units), Historic, 2000-2007 34
Table 21: Inhalation Systems, Mexico, Overall Volume (Units), Forecast,
2007-2012 35
Table 22: Inhalation Systems, Mexico, Average Price ($),
Historic, 2000-2007 36
Table 23: Inhalation Systems, Mexico, Average
Price ($), Forecast, 2007-2012 36
Table 24: Inhalation Systems,
Mexico, Distribution Share by Revenue ($mn), 2006-2007 36
Table 25:
Inhalation Systems, Mexico, Company Share by Revenue ($ mn), 2006-2007 37
Table 26: Currency Conversion from USD to Local Currency at 2007 Constant
Rate 54
1.2 List of Figures
Figure 1: Drug Delivery Devices
Cross Country Comparison (2000-2012) 18
Figure 2: Drug Delivery
Devices, Mexico, Overall Revenues ($ mn), 2000-2012 19
Figure 3: Drug
Delivery Devices, Mexico, Portfolio Analysis, 2000-2012 20
Figure 4:
Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Historic, 2000-2007
21
Figure 5: Drug Delivery Devices, Mexico, Overall Revenues ($ mn),
Forecast, 2007-2012 22
Figure 6: Drug Delivery Devices, Mexico,
Category Volume (Units), 2000-2012 23
Figure 7: Drug Delivery
Devices, Mexico, Category Volume (Units), Historic, 2000-2007 24
Figure 8:
Drug Delivery Devices, Mexico, Category Volume (Units), Forecast,
2007-2012 25
Figure 9: Drug Delivery Devices, Mexico Company share
(%), 2007 26
Figure 10: Infusion Systems, Mexico, Revenue ($ mn) by
Segment, Historic, 2000-2007 27
Figure 11: Infusion Systems, Mexico,
Revenue ($ mn) by Segment, Forecast, 2007-2012 28
Figure 12: Infusion
Systems, Mexico, Company Share (%), 2007 31
Figure 13: Inhalation
Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2007 32
Figure
14: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast,
2007-2012 33
Figure 15: Inhalation Systems, Mexico, Overall Volume
(Units), Historic, 2000-2007 34
Figure 16: Inhalation Systems,
Mexico, Overall Volume (Units), Forecast, 2007-2012 35
Figure 17:
Inhalation Systems, Mexico, Company Share (%), 2007 37
Figure 18: 3M
Healthcare Value Chain Analysis 39
Figure 19: Baxter International
Inc. Value Chain Analysis 43
Figure 20: Boehringer Ingelheim GmbH
Value Chain Analysis 46
Figure 21: Global Markets Direct Methodology 50
|
Related Report
|
View Cart
